UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
13.71
+0.22 (1.63%)
At close: Jul 8, 2025, 4:00 PM
13.70
-0.01 (-0.07%)
After-hours: Jul 8, 2025, 6:06 PM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $632.13 million as of July 8, 2025. Its market cap has increased by 3.71% in one year.
Market Cap
632.13M
Enterprise Value
558.09M
1-Year Change
3.71%
Ranking
Category
Stock Price
$13.71
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $632.13M, an increase of 247.52%. That is a compound annual growth rate of 16.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 622.00M | 38.41% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 693.83B |
| Johnson & Johnson | 373.59B |
| AbbVie | 331.43B |
| Novo Nordisk | 308.12B |
| UnitedHealth Group | 275.51B |
| Novartis AG | 240.05B |
| Abbott Laboratories | 232.62B |
| AstraZeneca | 216.19B |